Dahlof, B., Devereux, R.B., Kjeldsen, S.E., Julius, S., Beevers, G. and de Faire, U. (2002) Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study [LIFE]: A randomised trial against atenolol. Lancet, 359, 995-1003.
http://dx.doi.org/10.1016/S0140-6736(02)08089-3

has been cited by the following article:

• TITLE: The effect of controlling the ABC’s of diabetes on cardiovascular disease in a community-based endocrinology practice

  AUTHORS: Swarna Varma, Gretchen A. Piatt

  KEYWORDS: Diabetes; Endocrinology; Community

  JOURNAL NAME: Journal of Diabetes Mellitus, Vol.3 No.4, November 1, 2013

  ABSTRACT: Introduction: Large clinical trials demonstrate that glycemic, blood pressure, and cholesterol control lead to risk reduction in cardiovascular events. We determined whether A1c, blood pressure, and cholesterol control were associated with incident cardiovascular disease [CVD] in a community-based endocrinology practice over 10 years. Methods: 385 consecutive patients seen for diabetes management in a CBEP comprised the analysis cohort. To be included, a patient had ≥2 A1c, blood pressure, and LDLc measurements respectively without prevalent CVD. All patients were 18 years or older with a diagnosis of diabetes before or during calendar year 2000. Results: 17.6% of patients developed incident CVD over 10 years. After controlling for age, gender, and time, patients who improved their A1c to